Paglalarawan

DNA sequencing is a laboratory technique used to determine the exact sequence of bases (A, C, G, and T) in a DNA molecule. The DNA base sequence carries the information a cell needs to assemble protein and RNA molecules. DNA sequence information is important to scientists investigating the functions of genes. A study by StrategyHelix indicates that the global DNA sequencing market is expected to increase by US$ 28.7 bilyon mula sa 2022 sa 2028, garnering a CAGR of 18.1% sa panahon ng pagtataya.

Ang ulat ay nagbibigay ng napapanahong data ng laki ng merkado para sa panahon 2018-2021 at forecast na 2028 covering key market aspects like sales value for DNA sequencing. The global DNA sequencing market is segmented on the basis of product, sequencing type, application, at rehiyon. Batay sa produkto, the global DNA sequencing market is categorized into sequencing services, sequencing instruments, sequencing consumables, sequencing informatics. Sequencing services held the highest share in the global dna sequencing market. Gayunpaman, the sequencing informatics segment is forecast to register the highest CAGR during the forecast period 2022 – 2028. On the basis of sequencing type, the global DNA sequencing market has been segmented into next generation sequencing (NGS), sanger sequencing, iba pa ang iba. The NGS segment captured the largest share of the market in 2021. By application, the global DNA sequencing market has been segmented into applied, clinical, research. Sa mga tuntunin ng heograpiya, the global DNA sequencing market has been segmented into Asia Pacific, Europa, Hilagang Amerika, Pahinga ng Mundo (RoW). North America held the largest revenue share in 2021.

The global DNA sequencing market is highly competitive. Tulad ng 2021, the major players in the global DNA sequencing market were Adaptive Biotechnologies Corp., Agilent Technologies Inc., Ambry Genetics Corporation, BD (Becton Dickinson and Company), Berry Genomics Co. Ltd., BGI Group, Biodesix Inc., CareDx Inc., Centogene AG, Danaher Corporation, Devyser Diagnostics AB, Illumina Inc., Macrogen Inc., Merck KGaA, myDNA Inc., Natera Inc., NeoGenomics Laboratories Inc., New England Biolabs Inc., NGeneBio Co. Ltd., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., Personalis Inc., Qiagen N.V., Quest Diagnostics Inc., Roche Holding AG, SOPHiA GENETICS, TAKARA BIO INC., Thermo Fisher Scientific Inc.

Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the DNA sequencing market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

Saklaw ng Ulat

Produkto: sequencing services, sequencing instruments, sequencing consumables, sequencing informatics
Sequencing type: next generation sequencing (NGS), sanger sequencing, iba pa ang iba
Paglalapat: applied, clinical, research
Rehiyon: Asya Pasipiko, Europa, Hilagang Amerika, Pahinga ng Mundo (RoW)
Taon na itinuturing: Ang ulat na ito ay sumasaklaw sa panahon 2018 sa 2028

Mga Pangunahing Benepisyo para sa mga Stakeholder

– Get a comprehensive picture of the global DNA sequencing market
– Pinpoint ang mga sektor ng paglago at mga trend para sa pamumuhunan

Talaan ng mga Nilalaman

Bahagi 1. Panimula
– Saklaw ng pag aaral
– Panahon ng pag aaral
– Saklaw ng heograpiya
– Paraan ng pananaliksik
Bahagi 2. DNA sequencing market overview
Bahagi 3. Pagkasira ng merkado sa pamamagitan ng produkto
– Sequencing services
– Sequencing instruments
– Sequencing consumables
– Sequencing informatics
Bahagi 4. Market breakdown by sequencing type
– Next generation sequencing (NGS)
– Sanger sequencing
– Ang iba naman
Bahagi 5. Market breakdown by application
– Applied
– Clinical
– Research
Bahagi 6. Market breakdown by region
– Asya Pasipiko
– Europa
– Hilagang Amerika
– Pahinga ng Mundo (RoW)
Bahagi 7. Mga pangunahing kumpanya
– Adaptive Biotechnologies Corp.
– Agilent Technologies, Inc.
– Ambry Genetics Corporation
– BD (Becton, Dickinson and Company)
– Berry Genomics Co., Ltd.
– BGI Group
– Biodesix, Inc.
– CareDx, Inc.
– Centogene AG
– Danaher Corporation
– Devyser Diagnostics AB
– Illumina, Inc.
– Macrogen, Inc.
– Merck KGaA
– myDNA Inc.
– Natera, Inc.
– NeoGenomics Laboratories, Inc.
– New England Biolabs, Inc.
– NGeneBio Co., Ltd.
– Oxford Nanopore Technologies Limited
– Pacific Biosciences of California, Inc.
– PerkinElmer, Inc.
– Personalis, Inc.
– Qiagen N.V.
– Quest Diagnostics Inc.
– Roche Holding AG
– SOPHiA GENETICS
– TAKARA BIO INC.
– Thermo Fisher Scientific Inc.
Tungkol sa StrategyHelix
Pagtanggi